How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

AIMS: Enrollment criteria vary substantially among cardiovascular outcome trials (CVOTs) of sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2is), which impacts the relationship between a trial population and the general type 2 diabetes (T2D) population. The aim of this study was to evaluate the repr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Obes Metab
Main Authors: Birkeland, Kåre I., Bodegard, Johan, Norhammar, Anna, Kuiper, Josephina G., Georgiado, Elena, Beekman‐Hendriks, Wendy L., Thuresson, Marcus, Pignot, Marc, Herings, Ron M. C., Kooy, Adriaan
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2019
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590461/
https://ncbi.nlm.nih.gov/pubmed/30537226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13612
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki